Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral disodiumpyrophosphate absorption in pseudoxanthoma elasticum
2019-002109-24Phase 2Completed
- Sponsor
- Tampere University Hospital
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of disodium pyrophosphate in pseudoxanthoma elasticum (PXE), sponsored by Tampere University Hospital. Primary endpoints: Absorption curves of oral disodiumpyrophosphate and Adverse events. Started Jul 2019; status: completed.
02
Drugs
disodium pyrophosphate
03
Conditions
pseudoxanthoma elasticum (PXE)
Beyond the preview
Go deeper on 2019-002109-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002109-24.